July 2009 Educational Program
NATF-Hosted Educational Program
NATF held an educational dinner featuring international leaders in the fields of cardiovascular medicine, thrombosis, and hematology. This event was CME/CE accredited (2 hours) for physicians, nurses, and pharmacists.
Program Speakers:
Peter Libby, MD, Chief of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA
Peter Libby, MD, is the Chief of Cardiovascular Medicine at the Brigham and Women’s Hospital in Boston, Massachusetts. He also serves as the Mallinckrodt Professor of Medicine at Harvard Medical School. Dr. Libby directs the D.W. Reynolds Cardiovascular Clinical Research Center at Harvard. His current major research focus is the role of inflammation in vascular diseases such as atherosclerosis. Dr. Libby has received numerous awards and recognitions for his research accomplishments. His areas of clinical expertise include general and preventive cardiology. And More....
Atherothrombosis and Plaque Rupture
Slide Set Summary
Henri Bounameaux, MD, Professor of Medicine and Chairman of the Department of Medicine at the University of Geneva, Switzerland
Henri Bounameaux, MD graduated as MD in Basle, Switzerland in 1978. Board certified in internal medicine and vascular medicine, he became Director of the Division of Angiology and Hemostasis at the University Hospitals of Geneva in 1993. Since 2002, he is Professor of medicine at the University of Geneva and Chairman of the Department of Medicine. And More....
Slide Set Summary
Benjamin Brenner, MD, Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel
Benjamin Brenner qualified as a medical doctor from the Israel Institute of Technology in 1981. Following residency in internal medicine and hematology at the Rambam Medical Center in 1981-6, and a postdoctoral research fellowship in fibrinolysis at the University of Rochester, New York, USA, 1987-8, he returned to Haifa as a senior hematologist and was appointed as Director of the Thrombosis and Hemostasis Unit and Deputy Director of the Hematology Institute at Rambam Medical Center in 1994. Currently he is a Professor of Medicine (Hematology) and Caster chair in Leukemia Research at the Bruce Rapport Faculty of Medicine , Technion Israel Institute of Technology. And More....
Pregnancy and Thrombophillia
Slide Set Summary
The North American Thrombosis Forum (NATF) is a 501(c)3 nonprofit organization that focuses on unmet needs and issues related to thrombosis and cardiovascular diseases such as deep vein thrombosis, pulmonary embolism, myocardial infarction, peripheral arterial occlusive disease, and stroke.
Target Audience
This program is intended for physicians, nurses, physician assistants, pharmacists, hospitalists, and hospital administrators interested in thrombosis treatment and prevention.
Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
Accreditation/Designation Statements
For Physicians:
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Med-IQ designates this activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
For Nurses:
Med-IQ is accredited by the California Board of Registered Nursing to provide continuing education to nurses.
Provider approved by the California Board of Registered Nursing, Provider Number CEP 14745, for 2.0 contact hours.
For Pharmacists:
Med-IQ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
2.0 contact hours (0.20 CEUs) of credit for pharmacists. ACPE #476-999-09-001-L01-P. This program is designed for all pharmacists.
Acknowledgment of Commercial Support
As of June 19, 2009, this activity has been supported by educational grants from the following sponsors: Bristol Myers-Squibb, Canyon Pharmaceuticals, Covidien, Genentech, Lundbeck, Ortho-McNeil Janssen Scientific Affairs, LLC (Supported by an educational grant from Ortho-McNeil, Division of Ortho-McNeil Janssen Pharmaceuticals, Inc., administrated by Ortho-McNeil Janssen Scientific Affiars, LCC), and Sanofi-Aventis.